About FDA
Percent of NCTR advisory committee member positions vacant at the end of the month
Dictionary: Access to state-of-the-art, scientific expert advice to support agency decision making processes is imperative to the FDA advisory committee process. Having the fewest vacancies on our committees allows the agency to have ready access to those experts and supports the ability of FDA to meet its public health mission. For more information about FDA advisory committees, please visit http://www.fda.gov/AdvisoryCommittees/default.htm
Information is current as of December 31, 2012.
Fiscal Year - 2010
| Time | Target | Percent Vacant Positions |
|---|---|---|
| Oct 2009 | 10 | 33 |
| Nov 2009 | 10 | 11 |
| Dec 2009 | 10 | TBD |
| Jan 2010 | 10 | TBD |
| Feb 2010 | 10 | 11 |
| Mar 2010 | 10 | 11 |
| Apr 2010 | 10 | 11 |
| May 2010 | 10 | 11 |
| Jun 2010 | 10 | 11 |
| Jul 2010 | 10 | 33 |
| Aug 2010 | 10 | 33 |
| Sep 2010 | 10 | 33 |
Number of NCTR advisory committee member positions vacant at the end of the month
Fiscal Year - 2010
| Time | Target | Vacant Positions |
|---|---|---|
| Oct 2009 | N/A | 3 |
| Nov 2009 | N/A | 1 |
| Dec 2009 | N/A | TBD |
| Jan 2010 | N/A | TBD |
| Feb 2010 | N/A | 1 |
| Mar 2010 | N/A | 1 |
| Apr 2010 | N/A | 1 |
| May 2010 | N/A | 1 |
| Jun 2010 | N/A | 1 |
| Jul 2010 | N/A | 3 |
| Aug 2010 | N/A | 3 |
| Sep 2010 | N/A | 3 |
Total number of NCTR advisory committee member positions at the end of the month
Fiscal Year - 2010
| Time | Target | Positions |
|---|---|---|
| Oct 2009 | N/A | 9 |
| Nov 2009 | N/A | 9 |
| Dec 2009 | N/A | TBD |
| Jan 2010 | N/A | TBD |
| Feb 2010 | N/A | 9 |
| Mar 2010 | N/A | 9 |
| Apr 2010 | N/A | 9 |
| May 2010 | N/A | 9 |
| Jun 2010 | N/A | 9 |
| Jul 2010 | N/A | 9 |
| Aug 2010 | N/A | 9 |
| Sep 2010 | N/A | 9 |
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.
